Get the Stockscreener App
3.20
4.76%
-0.16
Myomo Inc stock is traded at $3.20, with a volume of 1.13M.
It is down -4.76% in the last 24 hours and down -31.62% over the past month.
Myomo, Inc., a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury. The company serves orthotics and prosthetics practices or clinics, as well as the veteran administration and other hospitals through orthotics and prosthetics providers, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Cambridge, Massachusetts.
See More
Previous Close:
$3.36
Open:
$3.37
24h Volume:
1.13M
Relative Volume:
2.51
Market Cap:
$175.58M
Revenue:
$25.24M
Net Income/Loss:
$-8.38M
P/E Ratio:
-13.91
EPS:
-0.23
Net Cash Flow:
$-9.54M
1W Performance:
-34.43%
1M Performance:
-31.62%
6M Performance:
-33.47%
1Y Performance:
-10.11%
1-Day Range:
$3.16
$3.47
1-Week Range:
$3.16
$4.89
52-Week Range:
$2.76
$7.1699
Myomo Inc Stock (MYO) Company Profile
Name
Myomo Inc
Sector
Industry
Phone
617-996-9058
Address
One Broadway, 14th Floor, Cambridge, MA
Compare MYO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MYO
Myomo Inc
|
3.20 | 175.58M | 25.24M | -8.38M | -9.54M | -0.23 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Myomo Inc Stock (MYO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-31-24 | Initiated | Craig Hallum | Buy |
| May-20-24 | Initiated | Lake Street | Buy |
| Dec-15-23 | Initiated | H.C. Wainwright | Buy |
| Nov-11-20 | Upgrade | ROTH Capital | Neutral → Buy |
| May-27-20 | Initiated | Dougherty & Company | Buy |
| Oct-02-17 | Initiated | H.C. Wainwright | Buy |
View All
Myomo Inc Stock (MYO) Latest News
Myomo outlines 2025 revenue target of $50M-$53M amid advancements in product and marketing strategies - MSN
Myomo, Inc. (NYSE:MYO) Q1 2025 Earnings Call Transcript - Insider Monkey
Financial Health Check: Examining Myomo Inc (MYO)’s Key Ratios - DWinneX
Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates - MSN
When the Price of (MYO) Talks, People Listen - news.stocktradersdaily.com
Myomo Inc Reports Strong Q1 Revenue Amid Challenges - TipRanks
Myomo (MYO) Stock Update: Analyst Lowers Price Target | MYO Stock News - GuruFocus
Craig-Hallum Adjusts Price Target for Myomo (MYO) After Mixed Q1 Report | MYO Stock News - GuruFocus
Myomo revenue jumps 162% to USD 9.8M in Q1 2025 - Medical Buyer
Myomo Inc (MYO) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic Innovations By GuruFocus - Investing.com Canada
Myomo Inc (MYO) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic Innovations - Yahoo Finance
Earnings call transcript: Myomo Q1 2025 reports strong revenue growth, stock dips - Investing.com
Myomo Reports Strong Q1 2025 Revenue Growth - TipRanks
Myomo earnings matched, revenue topped estimates - Investing.com
Myomo (MYO) Surpasses Q1 Revenue Estimates Amid Operational Challenges | MYO Stock News - GuruFocus
Myomo Reports First Quarter 2025 Financial and Operating Results | MYO Stock News - GuruFocus
Myomo reports Q1 EPS (8c), consensus (8c) - TipRanks
Myomo Reports First Quarter 2025 Financial and Operating Results - The Joplin Globe
Myomo Inc Reports Q1 2025 Earnings: Revenue Surpasses Estimates at $9.8 Million, EPS Matches Expectations at -$0.08 - GuruFocus
Myomo to Host Investor & Analyst Day Event on June 18, 2025 | MY - GuruFocus
Myomo to Host Investor & Analyst Day Event on June 18, 2025 - 01net
JPMorgan Chase & Co. Invests $581,000 in Myomo, Inc. (NYSEAMERICAN:MYO) - Defense World
Myomo to Report First Quarter 2025 Financial Results on May 7 - 01net
Myomo Launches the MyoPro® 2x | MYO Stock News - GuruFocus
Myomo unveils MyoPro 2x to enhance user independence - Investing.com
Myomo Launches the MyoPro® 2x - BioSpace
Myomo unveils MyoPro 2x to enhance user independence By Investing.com - Investing.com India
Myomo, Inc. (NYSEAMERICAN:MYO) Shares Sold by Rosalind Advisors Inc. - Defense World
Renaissance Technologies LLC Raises Holdings in Myomo, Inc. (NYSEAMERICAN:MYO) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
35,551 Shares in Myomo, Inc. (NYSEAMERICAN:MYO) Purchased by Russell Investments Group Ltd. - Defense World
Myomo Announces Upcoming Changes to its Board of Directors | MYO Stock News - GuruFocus
Myomo at Needham Conference: Strategic Growth and Market Expansion - Investing.com Australia
Myomo at Needham Conference: Strategic Growth and Market Expansion By Investing.com - Investing.com India
Myomo board members to depart at June annual meeting By Investing.com - Investing.com South Africa
Myomo Announces Upcoming Changes To Board - citybiz
Myomo board members to depart at June annual meeting - Investing.com Australia
Myomo Announces Board Transition with Director Departures - TipRanks
Myomo Announces Upcoming Changes to its Board of Directors - Bluefield Daily Telegraph
Myomo Reshapes Board Leadership Following Medicare Coverage Victory - Stock Titan
Myomo: Balancing CMS Tailwinds With Long-Term Risks (NYSE:MYO) - Seeking Alpha
(MYO) On The My Stocks Page - news.stocktradersdaily.com
Short Interest in Myomo, Inc. (NYSEAMERICAN:MYO) Expands By 22.3% - Defense World
Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference - The Joplin Globe
Medical Robotics Pioneer Myomo Reveals Growth Strategy at Major Healthcare Conference - Stock Titan
How the (MYO) price action is used to our Advantage - news.stocktradersdaily.com
Myomo (NYSEAMERICAN:MYO) Given New $11.00 Price Target at Ascendiant Capital Markets - Defense World
Long Term Trading Analysis for (MYO) - Stock Traders Daily
HC Wainwright Issues Optimistic Forecast for Myomo Earnings - Defense World
Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates - MSN
What is HC Wainwright’s Forecast for Myomo FY2026 Earnings? - Defense World
Myomo Inc Stock (MYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):